Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer-Reference-Cited by-同舟云学术

Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer

Published:2020-12-18 Issue:2 Volume:9 Page:848-852
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Koshizuka Keiichi¹^ORCID,Sakurai Daiju²,Sunagane Miki¹,Mita Yukiyoshi¹,Hamasaki Sawako¹,Suzuki Takeshi¹,Kikkawa Naoko¹,Nakano Michiyo³,Hanazawa Toyoyuki¹

Affiliation:

1. Department of Otorhinolaryngology/Head and Neck Surgery Chiba University Graduate School of Medicine Chiba Japan

2. Department of Otolaryngology, Head and Neck Surgery University of Yamanashi Kofu Japan

3. Department of Dermatology Chiba University Graduate School of Medicine Chiba Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.3695

Reference11 articles.

1. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

2. Toxic epidermal necrolysis

3. ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

4. Performance of the SCORTEN During the First Five Days of Hospitalization to Predict the Prognosis of Epidermal Necrolysis

5. Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12

2. Immune checkpoint inhibitor‐induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications;The Journal of Dermatology;2023-11-30

3. Nivolumab-induced Stevens-Johnson syndrome: Not only due to PD-1 inhibition;The Journal of Allergy and Clinical Immunology: In Practice;2023-09

4. Anti-PD‑1-induced type 1 diabetes mellitus in patient with recurrent oropharyngeal squamous cell cancer;Medical alphabet;2023-01-11

5. Steven-Johnson Syndrome: A Rare but Serious Adverse Event of Nivolumab Use in a Patient With Metastatic Gastric Adenocarcinoma;Journal of Medical Cases;2022-09